Dr Bonnie Li-macdonald, PHARMD | |
1221 Mercantile Ln, Upper Marlboro, MD 20774-5374 | |
(301) 618-5500 | |
Not Available |
Full Name | Dr Bonnie Li-macdonald |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 1221 Mercantile Ln, Upper Marlboro, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073928131 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 22415 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Bonnie Li-macdonald, PHARMD 10810 Connecticut Ave, Kensington, MD 20895-2138 Ph: () - | Dr Bonnie Li-macdonald, PHARMD 1221 Mercantile Ln, Upper Marlboro, MD 20774-5374 Ph: (301) 618-5500 |
News Archive
The researchers from Brigham and Women's Hospital this week have come up with a new study which shows that reducing the inflammation among patients who have already had a heart attack before could prevent the risk of getting more cardiovascular events. The study is published in the latest issue of the New England Journal of Medicine.
Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.
A review of previous studies indicates that people who currently smoke have an increased risk of developing type 2 diabetes, compared with non-smokers, according to an article in the December 12 issue of JAMA.
GenVec, Inc. (Nasdaq: GNVC) announced today that it has received a Phase 2 Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the development of GenVec's vector production technology.
Medgenics has announced that the latest, encouraging results of the Company's ongoing EPODURE Biopump Phase I/II Clinical Trial were presented at the 45th Conference of the Israeli Society of Nephrology and Hypertension, in Israel on March 27, 2009.
› Verified 8 days ago
Dr. Michael D Olaiya, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10908 Mount Lubentia Way, Upper Marlboro, MD 20774 Phone: 240-461-9554 | |
Sandy Apugo, DR. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10203 Brightfield Ln, Upper Marlboro, MD 20772 Phone: 240-476-8468 | |
Michelle D Harvey, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1221 Mercantile Ln, Upper Marlboro, MD 20774 Phone: 301-618-5500 | |
Richmond Muraguri, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9530 Crain Hwy, Upper Marlboro, MD 20772 Phone: 301-868-0303 Fax: 301-868-1812 | |
Simon Onukaogu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5100 Brown Station Rd, Upper Marlboro, MD 20772 Phone: 301-627-1500 | |
Yetunde A Olaniyi, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10500 Campus Way S, Upper Marlboro, MD 20774 Phone: 301-324-7098 |